Management of stage T1c prostate cancer
โ Scribed by Robert P. Gibbons
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 237 KB
- Volume
- 75
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: Clinical and pathological staging of prostate cancer has been, and remains, problematic. since prostate-specific antigen (psa)-detected tumors are often discerned during "screening," what are their significance? ## Methods: We analyzed 67 consecutive patients with stage t1c prostat
Transurethral surgery is the primary treatment for patients with superficial bladder cancer. Either electrical or laser thermal destruction is used most often but there is no proven therapeutic benefit for one method over the other. Treatment failure is usually a consequence of new tumor occurrence
## Background and Objectives: The natural history of stage A-1 (T1a) prostate cancer remains unpredictable. Although stage A-1 (T1a) was traditionally considered an indolent lesion, recent reports have documented the potential progression of stage A-1 (T1a) cancer. Methods: Eight men aged 65 to 76
For patients with lung cancer, the greatest hope for cure rests with patients with early stage disease. Surgery has been the standard of care for this group with the best 5-year survival of only 65% being achieved in patients with earliest pathologic Stage IA disease. Using strategies gained from th